GRI Bio, Inc.
GRI
$2.31
$0.062.67%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 15.11% | 17.22% | -1.99% | -41.27% | -46.13% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 45.42% | 35.62% | 19.90% | -22.02% | -26.05% |
| Operating Income | -45.42% | -35.62% | -19.90% | 22.02% | 26.05% |
| Income Before Tax | -45.66% | -36.07% | -20.91% | 26.67% | 37.04% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -45.66% | -36.07% | -20.91% | 26.67% | 37.04% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -45.66% | -36.07% | -20.91% | 26.67% | 37.04% |
| EBIT | -45.42% | -35.62% | -19.90% | 22.02% | 26.05% |
| EBITDA | -45.44% | -35.63% | -19.91% | 22.03% | 26.06% |
| EPS Basic | -12.79% | -- | -- | -- | -- |
| Normalized Basic EPS | -123.44% | -- | -- | -- | -- |
| EPS Diluted | -12.79% | -- | -- | -- | -- |
| Normalized Diluted EPS | -123.44% | -- | -- | -- | -- |
| Average Basic Shares Outstanding | 2,139.43% | -- | -- | -- | -- |
| Average Diluted Shares Outstanding | 2,139.43% | -- | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |